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AN INVESTIGATION OF IN VITRO PERCUTANEOUS PENETRATION 
ENHANCEMENT OF BENZOCAINE BY AZONE, 
DIMETHYLSULFOXIDE AND 2-PYRROLIDONE 
ABSTRACT OF THESIS 
This research utilizing full thickness human abdominal 
~skin was designed to assess the in vitro percutaneous pene-
tration of benzocaine by 1-dodecylazacycloheptan-2-one 
(Azone) , dimethylsulfoxide (DMSO) and 2-pyrrolidone (2-P) 
under conditions of constant thermodynamic activity in the 
vehicle. The solubilities of benzocaine in Azone and 
80/20, 60/40 and 40/60 V/V DMSO/water systems were found to 
be 254.17, 533.00, 68.60 and 2.51 mg/ml respectively. All 
three adjuvants demonstrated a significant but concentra-
tion-dependent enhancement of benzocaine penetration. On 
the basis of comparative analysis of the steady-state 
fluxes, Azone was most effective at the level of 5% V/V 
when drug concentration was twice the saturation solubility 
_jn the 20/80 PG/water gel. At higher Azone levels, any 
penetration enhancement effects were strongly negated by a 
corresponding decrease in skin/vehicle partitioning. Azone 
appeared to enhance penetration of benzocaine molecules by 
directly reducing the barrier function of the stratum 
'--' 
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corneum. DMSO-induced enhancement of benzocaine penetra-
tion was observed over 40/80% V/V DMSO. Pretreatment 
studies strongly suggested that enhancement by DMSO is due 
to a significant but temporary effect on the epidermal 
barrier. The moderate enhancement of benzocaine penetra-
tion shown by 80% 2-P in water could be due to a decrease 
in diffusional resistance of stratum corneum brought on by 
a slow interaction between the stratum corneum and 2-P. 
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INTRODUCTION 
The process of transdermal drug absorption offers a 
great challenge to research workers in the fields of 
pharmacy and dermatology. The skin is one of the most 
impenetrable tissues of the body, for it functions as a 
barrier against invasion by microorganisms and viruses and 
simultaneously limits the escape of physiologically essen-
tial components, such as water, from the body. For passage 
through the skin, the penetrating molecule must move first 
through the stratum corneum, then into the viable epidermis, 
the papillary layers of the dermis, and the capillary walls 
into the blood stream. The viable tissue layers and the 
capillaries are relatively permeable and the peripheral 
circulation sufficiently rapid so that diffusion through 
the stratum corneum itself is rate limiting for the great 
majority of substances (1,2). 
The stratum corneum consists of dense, highly com-
pressed, partially desiccated cells. This layer has 
regions rich in protein separated by a lipoidal framework. 
The stratum corneum is formed and continuously replenished 
by slow migration of cells from the germinative basal layer 
of the epidermis. Studies have shown that this layer is 
constantly regenerated about every two weeks in the mature 
adult (3). An electron micrograph of a highly magnified 
l 
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portion of the interior of a stratum corneum cell by Brady 
showed that this cell is filled with keratin filaments 
60-80 A0 in diameter, distributed in an amorphous matrix of 
mainly lipid and non-fibrous protein. The conversion of 
viable epidermal cells into dried, compact, keratin-
containing stratum corneum cells is the crucial event in 
the continuously developing epidermis that largely deter-
mines the low permeability of the skin. The filament-
matrix ultrastructure of the intracellular keratin appears 
to play a role in the mechanism of diffusion, particularly 
in accounting for the selective permeability of polar and 
nonpolar molecules. 
The mathematical expressions used to describe drug 
penetration through skin (4) are based upon the knowledge 
that passive diffusion is the predominant mechanism for 
penetration through human epidermis. Hence, Fick's law is 
generally applied to describe this process. Equation 1 
describes membrane-limited transport under steady-state 
conditions: 
D.P.,6C 
J = -------- (Eq. 1) 
h 
The flux, J, represents the amount of drug passing through 
the membrane system per unit area per unit time, D is the 
diffusion coefficient within the membrane, .6 C is the dif-
ference in concentration across the membrane, h is membrane 
thickness and P is the membrane/vehicle partition coefficient. 
3 
The equation allows one to identify the factors that may 
be manipulated so as to control percutaneous absorption, 
namely the concentration and the partition coefficient 
of the penetrant. Although membrane thickness may remain 
constant at a given site, each penetrant may encounter a 
different type of barrier and the efficiency of the process 
of penetration may be subject to the physical-chemical 
properties of both penetrant molecules and those surrounding 
the passage (5,6,7). 
Percutaneous absorption of local anesthetic agents 
has been the subject oa a number of reports (8,9,10). 
Benzocaine (ethyl aminobenzoate) is one of the most widely 
used local anesthetics in nonprescription products intended 
for relief of itch and pain. It has been reported (11) 
that local anesthetics in general are very poorly absorbed 
from the intact skin, but pass into the blood only if the 
skin is abraded or burned. This lack of efficacy of many 
nonprescription products in blocking the sensations of itch, 
burning and pain has also been supported by other in vivo 
studies of local anesthetics on intact and sunburned skin 
(12). Diffusion through the stratum corneum is the rate-
limiting step in benzocaine transport and this accounts 
for the reported lack of efficacy of many nonprescription 
products. 
The role of a vehicle in the transport of drugs into 
and through the skin is of fundamental importance for the 
4 
rational development of topical formulations. The physical- ;=;---~--
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chemical characteristics of the components of the vehicle 
are a major consideration in the selection of the vehicle. 
Substances may be more rapidly released from vehicles 
having a low affinity for the penetrant. Vehicles with 
relatively low solvent power for incorporated compounds may 
induce more rapid penetration (13). In general, a compound 
must be at least partially soluble in its vehicle so that 
it can be readily released into the skin. High solubility 
may result in preferential retention of the drug in the 
vehicle. The physical properties of the components of the 
i- vehicle are also important in the degree of occlusion they 
provide leading to water retention in the stratum corneum 
layer. 
A general approach towards affecting the topical bio-
availability of drugs is to incorporate adjuvants which may 
either favor a high drug concentration in the stratum 
corneum or directly or indirectly affect the barrier 
function of the skin (14,15,16). 
There are many formulations or substances which, when 
applied to the skin, can alter its suppleness and permea-
bility properties which, in turn, depend to a large extent 
on the state of the stratum corneum. Of major interest are 
those substances which have a mild or even a reversible 
effect on the tissue. With these substances it may be 
possible to alter temporarily the properties of the skin 
5 
to promote effective drug delivery for both local and/or 
systemic effect. 
Both ionic and nonionic surfactants have been inves-
tigated as adjuvants in dermatologic preparations for the 
purpose of enhancing the drug solubility and/or lowering 
the resistance to drug penetration without much success. 
For example, in a recent study of the effect of nonionic 
surfactants on benzocaine penetration through hairless 
mouse skin, Dalvi and Zatz (17) found that polyoxyethylene 
nonylphenol, a nonionic surfactant, produces a concentration-
dependent increase in benzocaine solubility in water. The 
in vitro skin penetration flux, however, was found to be 
dependent only on the free benzocaine concentration in 
solution rather than total drug concentration in solution 
due to micellar entrapment. 
Dimethylsulfoxide (DMSO), a polar, relatively nontoxic 
organic solvent, has been shown by many investigators to be 
an effective vehicle for increasing skin penetration (18,19, 
20,21). Stoughton and Fritsch (18) have presented conclu-
sive evidence to show that DMSO promotes the cutaneous 
penetration, in vivo, of the following substances: (a) a 
vasoconstrictor, naphazoline (Privine) hydrochloride; (b) an 
antiperspirant, hexopyrronium bromide; and (c) a cortico-
steroid, fluocinolone acetonide; and in vitro, hexopyrronium 
chloride and cortisol. It has also been shown that DMSO 
enhances the penetration of water. An approximately 20-fold 
r=I----
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increase in the water transpiration rate occurs in vivo 
as compared with a 50-fold increase in water permeation 
through excised skin (2). DMSO lowers the skin's resistance 
to drug permeation but the specific mechanism is not fully 
understood. Kligman (2) has shown that the enhanced pene-
tration offered by DMSO was largely reversible and little 
permanent damage to the stratum corneum occurred when it was 
removed and the tissue rehydrated. The application of 
DMSO to a biological membrane, such as the skin, effects 
a nonselective increase in tissue permeability which is not 
unique to DMSO but can be demonstrated, in varying degrees, 
by many other hypertonic solutions. In addition, there is 
a more specific property of DMSO which facilitates the 
movement of DMSO (and compounds which it has dissolved) 
across the skin and this appears to be the result of an 
increase in the size of passive flux channels through the 
membrane (19). This phenomenon may explain why compounds 
which are not well absorbed percutaneously from traditional 
vehicles may exhibit a dramatic increase in penetration 
when dissolved in DMSO (20). 
Azone (1-dodecylazacycloheptan-2-one) has recently 
been shown to enhance the biologic activity of various 
topically active agents such as antibiotics and anti-
fungals, glucocorticoids and antipsoriatic agents (22, 
23). It is a colorless and relatively odorless compound 
that is non-irritating even when applied undiluted to the 
7 
human skin surface .. The penetration-enhancing effect of 
~ -----
Azone was observed with concentrations as low as 1%, which 
is much lower than that required with other enhancers, such 
as urea, DMSO and N,N-dimethylformamide. In addition, ;::::; -
A7.one caused practically no irritation t'J human skin even 
at concentraticns of more ~han 50%. In light of these 
advantages, this substance has aroused considerable inter-
est as a drug penetration enhancer for topical pharmaceu-
tical formulations intended for both local and systemic 
effects. 
Percutaneous penetration of both hydrophobic and 
hydrophilic molecules is enhanced with Azone, although 
more dramatic enhancements are usually seen with hydrophilic 
drugs. Stoughton (22) has shown that Azone significantly 
enhances the penetration of both anthracene, a hydrophobic 
compound, and 8-bromocyclic adenylic acid, a strongly 
hydrophilic compound. At low concentrations of anthracene, 
no penetration was observed without Azone and good penetra-
tion was observed with Azone. As the concentration of 
anthracene was raised, the effect of Azone was reduced 
until high concentrations of the drug showed little or no 
enhancement. Stoughton explained the foregoing result on 
the basis of the fact that a highly hydrophobic agent, when 
present in high concentrations, can penetrate the skin well 
enough so that it prevents Azone from acting to provide 
any additional effect. Examination of the effect of Azone 
8 
on 8-bromocyclic adenylic acid revealed that the steady-
r, --
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state rate of penetration of this compound through hairless 
mouse skin in vitro was enhanced 12-fold with 1% Azone 
relative to control. The precise mechanism is unknown, but 
it has been postulated that Azone alters the lipid and 
protein structures of the skin. Radioactive studies have 
shown that Azone is bound in the epidermis and corium and 
that relatively little is released from the skin. 
Recently, 2-pyrrolidone has been investigated for 
potential skin penetration-enhancing properties by Barry 
and Southwell (24). They measured the steady-state fluxes 
in vitro ~or polar methanol, non-polar octanol, and an 
intermediate compound, caffeine, using human stratum 
corneum, and determined partition, permeability and the 
apparent diffusion coefficient. It was concluded that 
2-pyrrolidone enhances permeation through the polar route 
of the skin by increasing the diffusivity, and reduces 
passage through the nonpolar route by decreasing diffusivity 
and partitioning. Stoughton (25) and coworkers combined 
2-pyrrolidone with clindamycin in the treatment of acne 
vulgaris and suggested that the compound aided penetration 
of clindamycin into the comedo. In a study, five patients 
used clindamycin phosphate in 2-pyrrolidone for periods 
from 7 to 19 weeks. All five had complete suppression of 
growth of the acne organism in open comedones. 
9 
Low molecular weight polyols are used extensively in r=r--
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cosmetic and dermatologic practice. Propylene glycol in 
particular has been shown to increase the aqueous solu-
bility of many drugs and also enhances their skin pene-
tration when used as a cosolvent with water (26,27,28). 
Recently, Lam (29) has examined a series of propylene 
glycol/water blends as potential vehicles for topical 
preparations of benzocaine. The role of Azone as percu-
taneous penetration enhancer for benzocaine solution in 
60/40 propylene glycol/water was extensively investigated. 
The in vitro skin penetration of benzocaine from a series 
of dimethyl sulfoxide/water blends was also studied using 
human cadaver skin. These studies document penetration-
enhancing effects of propylene glycol, dimethylsulfoxide 
and Azone primarily under conditions of decreasing thermo-
dynamic activity. Could benzocaine penetration flux be 
further maximized by manipulating the concentration of 
drug, solvent or the penetration accelerator? Does the 
enhancement of benzocaine penetration by Azone involve a 
direct effect on the skin? What is the contribution of 
Azone as a solvent for benzocaine? How does it influence 
skin-vehicle partitioning? These are some of the questions 
that still need to be addressed. 
10 
Scope of the Present Study 
This study was designed to help answer some of the 
aforementioned questions and further refine the formulation 
parameters for a topical preparation of benzocaine. In 
vitro skin penetration of benzocaine will be examined 
under conditions of constant thermodynamic activity with 
respect to penetrant benzocaine from 20/80 propylene glycol/ 
water and dimethyl sulfoxide/water systems. The scope of 
Azone as a penetration accelerator will be further scruti-
nized to define its appropriate level of concentration in 
the vehicle and to shed more light on its mode of action 
as a penetration enhancer. In view of recent reports, the 
effect of 2-pyrrolidone on percutaneous penetration of 
benzocaine will also be examined. 
EXPERIMENTAL 
J'.1aterials 
Benzocaine, 1 propylene glycol 2 (PG), dimethyl-
sulfoxide3 (DMSO), Azone, 4 2-pyrrolidone 5 (2-P), kluce1 6 
(hydroxypropyl cellulose), saline, 7 absolute ethano1, 8 and 
double distilled water. 9 All chemicals were used as 
received from the manufacturers. 
Solubility Studies 
The solubility of benzocaine in pure Azone was deter-
mined at 25° ± 0.5°C by magnetically stirring a known 
excess amount of the drug in 5 ml Azone in a 10-ml glass-
stoppered Erlenmeyer flask for a period of 48 hours. The 
stirring was stopped and an aliquot of the supernatant was 
filtered and appropriately diluted with ethanol. The study 
was done in duplicate and the concentration of benzocaine 
was determined spectrophotometrically at 252 nm. The 
1 "Baker" Grade, Lot. 847340, J. T. Baker Chemical Co., 
Phillipsburg NJ. 
2 USP Grade, Lot. 909349, J. T. Baker Chemical Co., 
Phillipsburg NJ. 
· 3 "Baker Analysed" Lot. 805340, J .. T. Baker Chemical Co., 
Phillipsburg NJ. 
4 Lot. 0157-132, Nelson Research, Irvine CA. 
5 Lot. 713381, Fisher Scientific Comp., Fair Lawn NJ. 
6 HF grade, Lot. 3027, Hercules Inc., Wilmington DE. 
7 Sodium Chloride Injection USP, McGaw Lab., Irvine CA. 
8 Ethyl Alcohol USP, Dl-19425, Gold Shield Chemical Corp., 
Hayward CA. 
9 Univ. of the Pacific, Stockton CA. 
11 
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saturation solubility of the drug in Azone was obtained 
from the standard curve pretested for compliance with 
Beer's law. 
The solubility of benzocaine in a series of DMSO/water 
mixtures (40 to 80% in 20% increments) was determined 
gravimetrically. An excess of benzocaine was weighed and 
added to 25 ml of DMSO/water mixtures in 50-ml glass-
stoppered Erlenmeyer flasks containing a Teflon-coated 
magnetic stirring bar. The solution was stirred for a 
period of 48 hrs at 25° ± 0.5°. Drug was allowed to 
settle. The supernatant was filtered, and a known volume 
was placed in a preweighed 50-ml round bottom flask. The 
solvent was removed in vacuo10 (rotatory evaporator) and 
the flask was reweighed to a constant weight to calculate 
the saturation solubility in each of these systems. Each 
determination was done in duplicate. 
Preparation of Test Solutions, 
Suspensions and Gels 
All solutions were prepared on a volume/volume basis 
unless indicated otherwise. Excess amounts of benzocaine 
were accurately weighed and carefully dispersed in the 
following media: 
a. Propylene glycol in water (20 and 60% V/V) 
b. Dimethylsulfoxide in water (40, 60, and 80% V/V) 
c. 2-Pyrrolidone in water (10, 20, 40, and 80% V/V) 
10 Rotavapor R-110/RE-120, Duchi Lab., w. Germany. 
q-
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The dispersions of benzocaine in propylene glycol/water 
(20/80) were gelled with 4% (W/V) hydroxypropyl cellulose, 
after adding the proper concentration of Azone for the 
purpose of testing for the effect of this adjuvant as a 
skin penetration enhancer. 
In Vitro Skin Penetration Studies 
Skin Preparation: Full thickness human abdominal skin 
was obtained at autopsy and kept frozen until ready for 
use. Before the experiment, the skin was removed from the 
freezer and allowed to thaw gradually at room temperature. 
When the sample was pliable, it was placed epidermal side 
down on a dissecting board. All subcutaneous fat was then 
carefully removed with a scalpel. A section of .skin 
derived fro~ a single subject yielded skin pieces for 8-10 
diffusion cells. 
Skin Diffusion Cell: The cell consists of two parts 
(Fig. 1). The bottom part is a glass chamber with a sam-
pling port and is enclosed by a water jacket which allows 
for circulation of water at selected temperature. A 
11 Teflon-coated magnetic stirring bar was placed at the 
bottom of the chamber to ensure good mixing. The skin 
piece was placed in position on an 0-ring between the two 
ball joints of the top and bottom chambers, providing a 
diffusion area of 2.01 sq. em. 
11 Spinbar, V.W.R., San Francisco CA. 
Outflow 
~~~~~;:---Top Chamber 
+ltH~~~~o~~ Ring Groove 
'------r---Skin 
Water Jacket 
14 
Figure 1. Diagrammatic representation of the diffusion cell 
used in penetration studies. 
i-'i --
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The top chamber was covered with parafilm and/or 
plastic wrap during all penetration studies to provide 
occlusion. Normal saline (6.2 ml) was injected into the 
1 h b b f . d . f b. 12 ower c am er y means o a syr1nge an a p1ece o tu 1ng. 
Air bubbles that might be trapped on the dermal side of 
the skin were allowed to escape via the sampling port by 
carefully tilting the skin cell. Each cell was mounted on 
a magnetic stirrer. The temperature of the receptor fluid 
in the lower chamber was maintained at 37° ± 0.5° by circu-
lating water from a constant-temperature water bath fitted 
13 
with a circulator pump. The skin sample was allowed to 
equilibrate in this condition overnight. Before any formu-
lation was applied to the skin, the saline in the bottom 
chamber was removed and replaced with fresh saline. Approxi-
mately 2 ml of the test formulation was applied to the skin 
surface in all cases. 
All experiments were carried out for 12 hrs. Samples 
were withdrawn at appropriate time intervals and analyzed. 
Pretreatment Studies: Unless otherwise indicated, 
all pretreatment studies involved surface application of 
· the pure adjuvant on the excised human skin, mounted on 
the skin cell, for a predetermined period of time. Pieces 
were then rinsed with ethanol followed by water and wiped 
with a cotton swab to ensure complete removal of the excess 
12 Norton Corp., Akron OH. 
;L3 Haake Model-FE, v.~'iT.B. I San Francisco CA. 
• 
16 
adjuvant prior to conducting drug penetration experiment. 
'1--
Pretreatment by soaking involved total immersion of 
the skin sample in the selected adjuvant for a predeter-
mined period of time followed by the removal of excess ~ -
adjuvant by successive rinsing with ethanol and water. The 
complete removal of excess adjuvant and water v-Jas ensured 
by wiping with a cotton swab as before. 
Assay Procedure 
Analyses for benzocaine in the receptor fluid were 
14 done on a spectrophotometer fitted with a micro flow-
through attachment. This allowed for small sample size and 
rapid sampling. The absorbance was recorded at 252 nm (29) 
and converted into concentration by means of a standard 
curve. Beer's law was obeyed throughout the concentration 
range studied (2.5 to 20.0 mcg/ml) (see Appendix A and B). 
Data Treatment 
Each release experiment was performed in duplicate and 
the average data were then used to draw the individual 
graphs plotting the amount penetrated per unit area against 
time. Regression analyses were performed on all of these 
plots to obtain penetration rates and other regression 
parameters followed by testing for paralellism and calcu-
lating the 95% confidence limits for each slope. 
14 Spectronic 710, Bauch and Lomb, Rochester NY. 
RESULTS 
In these studies, in vitro penetration of benzocaine 
across human cadaver skin has been examined from a series 
of aqueous formulations primarily under conditions of maxi-
mum thermodynamic potential achieved by incorporating the 
drug in excess of its solubility in respective vehicles. 
The formulations included selected blends of Azone/PG/ 
water, DMSO/water, and 2-P/water. The effects of Azone, 
DMSO, and 2-P upon percutaneous penetration of benzocaine 
were evaluated by either applying the appropriate formula-
tion directly to the skin or by pretreating the skin with 
pure adjuvant. Since Azone is immiscible in aqueo'lS sys-
terns, various Azone/PG/water blends were gelled with 4% 
hydroxypropyl cellulose to achieve uniform dispersion. 
The following pages document the solubility and pene-
tration data generated during the course of this investi-
gation and also provide an analysis and interpretation of 
these results. 
Solubility Studies 
The solubilities of benzocaine in 40, 60, and 80 percent 
DMSO/water at 25° ± 0.5° are shown in Table I. 
The solubility of benzocaine in PG/water systems has 
been previously shown (29) to have a range of 2.00 mg/ml in 
water to 123.75 mg/ml in pure propylene glycol. The 
17 
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-TABLE I 
Solubility of Benzocaine in DMSO/Water Mixtures 
at 25° ± 0.5° 
DMSO/Water 
(% V /V) 
80/20 
60/40 
40/60 
Solubility (mg/ml) 
533.00 
68.60 
2.51 
Percentage 
Solubility 
53.3 
6.86 
0.25 
18 
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solubility of benzocaine in 20% and 60% propylene glycol 
in water (vehicles used during this study) was found to 
be 4.25 and 17 mg/ml respectively. 
The solubility of benzocaine in Azone at 25° ± 0.5° 
was found to be 254.17 mg/ml in sharp contrast to its 
solubility of 4.25 mg/ml in 20% PG/water. 
Penetration Studies 
Unless otherwise indicated, all penetration studies 
were conducted in duplicate and initiated using a known 
excess of the drug in the vehicle. The penetration data 
obtained from all studies were tabulated and analyzed by 
plotting the mean amount penetrated per unit area (Q) 
against time (T). The regression analyses of the plots 
were performed and 95% confidence limits of the steady-
state regions of the penetration curve were established 
15 
using a programmable calculator. The regression lines 
were extrapolated to the time axis to determine the 
intercepts. 
19 
In order to overcome the variation due to skin samples 
from different donors and to effectively compare the results 
of various experiments, a standard control containing 
20 mg/ml of benzocaine in 20/80 PG/water was included in 
all major experiments. The observed steady-state fluxes 
2 
of the control ranged from a low of 25.17 meg/em /hr to a 
15 TI Prograrnrnable 59, Texas Instruments, Dallas TX 
;:: 
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high of 64.57 mcg/cm2/hr with an average of 42.16 mcg/cm2/ 
""!----
~ --
hr. This variation in flux values for the same control is 
mostly attributable to the variability in human skin samples 
from different donors and may be due to any number of fac-
tors such as skin age, skin condition, ethnic differences 
and skin metabolism (8). This variability has been con-
sidered in the design of all experiments. 
DISCUSSION 
To assure penetration of a drug from a vehicle, one 
approach utilizes the differences in thermodynamic activi-
ties of the penetrant between the vehicle and the membrane 
phases. Ideally, such vehicles "push" the drug into the 
skin without causing detectable injury to the skin membrane. 
Intuitively one would choose a vehicle that results in a 
relatively high thermodynamic activity of the active 
ingredient in the formulation. In the study by Lam (29) 
this was accomplished by using a near-saturated solution 
of benzocaine. However, benzocaine concentration in the 
applied vehicle suffered significant decline over the 
duration of the experiment (12-24 hours), making it diffi-
cult to interpret the data. This problem was overcome in 
the present study by maintaining constant thermodynamic 
flux in the donor vehicle with an excess of drug. 
PG/Water System 
The effect of benzocaine concentration on its penetra-
tion profiles from.20/80 PG/water is shown in Table II and 
Figure 2. Five different concentrations, covering a wide 
range above and below the saturation solubility of the drug 
in 20/80 PG/water system (4.25 mg/ml), were chosen to study 
the effect of benzocaine concentration. The steady state 
fluxes were found to increase significantly with increasing 
21 
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TABLE II 
The Penetration Pattern of Benzocaine from 20/80 
PG/Water Gel as a Function of 
Benzocaine 
Concentration 
(mg/ml) 
1 
3 
5 
10 
20 
Its Concentration 
Flux 
(Mcg/Cm2jHr) 
12.13 (±1.26) 
20.55 (±2.40) 
29.51 (±2.64) 
36.61 (±2.46) 
37.23 (±1.29) 
Correlation 
Coefficient 
( r) 
0.992 
0.990 
0.994 
0.997 
0.999 
Fluxes increased significantly with increasing drug 
concentration from 1 to 10 mg/ml (P < 0.01). 
Intercept 
(Hrs) 
-2.70 
-2.50 
-2.02 
-1.42 
-0.29 
There was no significant difference in the fluxes of 10 
and 20 (P > 0.50). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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Figure 2. The Penetration Pattern of Benzocaine from 20/80 
PG/Water Gel as a Function of its Concentration. 
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drug concentration up to 10 mg/ml. At this point, doubling 
the drug concentration did not cause a significant change 
in its penetration rate. 
Azone/PG/Water System 
A preliminary study examined the penetration pattern 
of benzocaine at concentration levels of 3, 5 and 10 mg/ml 
in 20/80 PG/water gel containing 5% Azone (Table III, 
Fig. 3). Approximately 30% decline in the flux associated 
with a drop in drug concentration from 5 to 3% in the 
absence of Azone (Table II) is completely reversed in the 
presence of 5% Azone. The fluxes for both 3 and 5% benzo-
caine were almost equal. The presence of Azone in the 
formulation, at a benzocaine level below its saturation 
solubility in the vehicle, apparently helped to overcome 
the thermodynamic deficit resulting from very low drug 
concentration, therefore enhancing the penetration through 
the skin. 
On the basis of Lam's work (29), three Azone concen-
trations (1, 5 and 10%) were chosen for the penetration 
Iii 
study conducted at the benzocaine concentration of 20 mg/ 
ml. As can be seen From Table IV and Fig. 4, a statis-
tically significant increase in the flux (P < 0.05) rela-
tive to control resulted from applying the system containing 
1% Azone. The delivery systems containing 5% and 10% Azone 
did not significantly enhance the cutaneous penetration of 
TABLE III 
The Penetration Pattern of Benzocaine from PG/Water 
20/80 Gel Containing 5% V/V Azone 
25 
Benzocaine 
Concentration 
(mg/ml) 
Flux 
(Mcg/Cm2 /Hr) 
Correlation 
Coefficient 
(r) 
Intercept 
(Hrs) 
3 
5 
10 
10.21 (±1.14) 
9.94 (±0.95) 
12.80 (±0.67) 
0.991 -3.27 
0.993 -2.70 
0.998 -2.32 
The flux from 3 mg/ml drug level showed no significant 
different as compared to that of 5 mg/ml level (P > 0.20). 
There was a significant difference in the fluxes of 5 and 
10 mg/ml level (P < 0.01). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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Figure 3. The Penetration Pattern of Benzocaine from 
PG/Water 20/80 Gel Containing 5% V/V Azone. 
Q versus t plot. 
Key: Drug cone. (mg/ml) • 3 0 5 • 10 
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TABLE IV 
Effect of Azone Concentration on Percutaneous Penetration 
of Benzocaine from 20/80 PG/Water at 
Drug Level of 20 mg/ml 
Azone Correlation 
Concentration Flux Relative Coefficient 
(% V/V) (Mcg/Cm2 /Hr) Rate ( r) 
10 26.60 (±1.80) l. 06 0.995 
5 26.25 (±1.44) l. 04 0.997 
1 28.17 (±l. 62) 1.12 0.996 
Con trol-l 25.17 (±1.21) 1 0.997 
Control-1 = 20 mg/ml benzocaine suspension in 20/80 
PG/water gel. 
Intercept 
(Hrs) 
-l. 86 
-1.61 
-l. 42 
-l. 82 
The fluxes obtained from systems containing 5 and 10% Azone 
showed no significant difference as compared to control 
(P > 0.10) but flux from system containing 1% Azone was 
significantly different from that of control (P < 0.05). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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Figure 4. Effect of Azone Concentration on Percutaneous 
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benzocaine. When the experiment was repeated under iden-
;:=;-
tical conditions at benzocaine concentration level of 
10 mg/ml, the drug penetration rate from the vehicle with 
1% Azone was approximately the same as the control; however, 
benzocaine flux was found to decrease significantly (P < 
0.01) with increasing Azone concentration (Table V, Fig. 5). 
In yet another study under similar conditions (Table VI, 
Fig. 6), when initial benzocaine concentration of the four 
formulations (including control) was adjusted to twice the 
respective total solubility, the corresponding fluxes from 
the formulations containing 1 and 10% Azone were signifi-
cantly greater (P < 0.01) than that of the control. The 
flux from the vehicle containing 5% Azone was very signifi-
cantly different (higher) (P < 0. 001) from the control 
value and was also higher than the flux value for vehicle 
with 10% Azone. These data reveal that skin penetration 
enhancement effects of Azone are a function of its concen-
tration and there appears to be an optimum Azone level for 
obtaining maximum flux. The relative magnitude of the 
fluxes from the formulations containing 1, 5 and 10% Azone 
relative to control in each study can be explained by 
considering total drug concentration in each formulation 
in relation to its saturation solubility in the vehicle and 
taking into account that the solubility of benzocaine in 
Azone is approximately 60 times that in 20/80 PG/water, 
indicating a high affinity for benzocaine. Based upon the 
30 
TABLE V 
Effect of Azone Concentration on Percutaneous Penetration 
of Benzocaine from 20/80 PG/Water Gel at 
Azone 
Concentration 
(% V/V) 
10 
5 
1 
Con trol-l 
Drug Level of 10 mg/ml 
Flux 
(Mcg/Cm2/Hr) 
10.13 (±LOS) 
12.80 (±0.67) 
22.96 (±1.12) 
22.42 (±1.46) 
Relative 
Rate 
0.45 
0.57 
1. 02 
1 
Correlation 
Coefficient Intercept 
(r) (Hrs) 
0.992 -3.06 
0.998 -2.32 
0.998 -0.84 
0.997 -0.99 
Control-1 = 10 mg/ml benzocaine suspension in 20/80 PG/ 
water gel with no Azone. 
Fluxes decreased significantly with increasing Azone 
concentration (P < 0.01). 
There was no significant difference between the rates of 
control and 1% (P > 0.20). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
;=J---
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Figure 5. Effect of Azone Concentration on Percutaneous 
Penetration of Benzocaine from 20/80 PG/Water 
Gel at Drug Level of 10 mg/ml. Q versus t plot. 
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TABLE VI 
Effect of Azone Concentration on Percutaneous Penetration of Benzocaine 
from 20/80 PG/Water Gels 
Azone 
Concentration 
(% V /V) 
10 
5 
1 
Con trol-l 
Benzocaine 
Concentration 
(mg/ml) 
60 
35 
15 
10 
Flux 
(Mcg/Cm2/Hr 
21.15 (±1.97) 
24.91 (±2.01) 
22.24 (±2.07) 
17.36 (±1.85) 
Relative 
Rate 
1.22 
1.44 
1. 28 
1 
Cantral-l = PG/water 20/80 gel containing 10 mg/ml drug. 
Correlation 
Coefficient 
( r) 
0.991 
0.994 
0.991 
0.989 
Concentration of benzocaine in each system was double the saturation solubility. 
Intercept 
(Hrs) 
-6.93 
-7.24 
-6.08 
-2.38 
The fluxes obtained from systems containing 1 and 10% Azone showed a highly significant 
difference from control (P < 0.01) and that from the system containing 5% Azone showed a 
very highly significant difference from that of control (P < 0.001). 
The numbers in parentheses indicate 95% confidence limits of the respective slope. 
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Figure 6. Effect of Azone Concentration on Percutaneous 
Penetration of Benzocaine from 20/80 PG/Water 
Gels. Q versus t plot. 
Key: Azone cone. (V/V) 0 10% • 5% 0 1% 
• Control-1 
33 
-
--
=--== 
~ ---
--
~ 
=~ 
-
-
-= ~
~ 
~ 
34 
solubility data, the saturation solubilities of benzocaine 
in the 20/80 PG/water formulations containing 1, 5 and 10% 
Azone were calculated to be 6.7, 16.5 and 29 mg/ml, respec-
tively. The data for 10% Azone in Table IV suggest that 
drug depletion might have masked the penetration enhancement 
effect of Azone since the actual drug level of 20 mg/ml 
was well below the saturation level of 29 mg/ml. The plots 
of Figure 4 showing essentially a straight-line release 
over 12-hour duration negate this possibility. However, 
drug depletion effects do appear to contribute to the 
decline in flux when the drug concentration is cut in half 
to 10 mg/ml (Table V, Fig. 5). It is significant to note 
that flux declined when Azone concentration was increased 
from 5 to 10% even under conditions of constant thermo-
dynamic potential (Table VI, Fig. 6). Collectively, the 
aforementioned observations lend strong support to the 
conclusion that benzocaine has a high degree of affinity 
for Azone and (at high levels of Azone) any penetration 
enhancement effects are strongly negated by a corresponding 
decrease in the skin/vehicle partition coefficient. Among 
the Azone concentrations investigated, 5% Azone generates 
maximum flux under conditions of constant thermodynamic 
activity of benzocaine in 20/80 PG/water gels. This work 
confirms the earlier findings of Lam (29) with respect to 
penetration effects of Azone on benzocaine incorporated in 
60/40 PG/water gels at near-saturation level. 
Effect of Azone Pretreatment 
of Human Cadaver Skin 
35 
This set of experiments was conducted to determine if 
the observed penetration enhancement effects of Azone were 
in part or whole due to any direct effects on the skin 
tissues. The basic strategy involved pretreating the 
excised human cadaver skin with neat Azone either by surface 
application or soaking prior to use in the drug penetration 
experiments. The surface treatment involved application 
of neat Azone to the epidermal surface of the skin mounted 
on the diffusion cell or soaking the skin sample in the 
neat Azone for an hour. In either case, after the removal 
of excess Azone, the skin was washed with ethanol followed 
by water and surface dried. The penetration profiles were 
then monitored. Two control preparations, with and without 
Azone, were used in these studies. 
The penetration profiles of benzocaine following 
surface application of neat Azone for one, thirty and sixty 
minutes revealed that fluxes from the pretreated samples 
were significantly greater than either control (Table VII, 
Fig. 7) and were independent of the duration of exposure 
with the penetration enhancer. The results were similar 
when the presoaked and surface-treated samples were corn-
pared (Table VIII, Fig. 8). Together, these pretreatment 
studies reveal that Azone facilitates penetration of benzo-
caine molecules across human skin by directly reducing the 
barrier effect of stratum corneum. The water-rich dermal 
36 
TABLE VII 
Effect of Azone Pretreatment (Surface) on Percutaneous 
Penetration of Benzocaine from 20/80 
PG/Water Gel 
Correlation 
Skin Flux Relative Coefficient Intercept 
Condition (Mcg/Cm2/Hr) Rate ( r) 
1-min 
pretreatment 40.19 (±4. 29) l. 32 0.989 
30-min 
pretreatment 43.12 (±3.51) l. 41 0.995 
1-hr 
pretreatment 41.67 (±3.56) l. 37 0.995 
Contro1a 30.51 (±1.19) 1 0.999 
Contro1b 34.40 (±4.01) 1.13 0.990 
Drug concentration in all preparations was 20 mg/ml. 
aControl - No pretreatment.· 
(Hrs) 
-1.61 
-1.51 
-1.82 
-0.99 
-2.44 
bcontrol - No pretreatment. 5% Azone in the preparation. 
The fluxes from pretreated skin were significantly different 
from controls (P < 0.01). 
The numbers in parentheses indicate 95% confidence limits of 
the respective slope. 
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Percutaneous Penetration of Benzocaine from 
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TABLE VIII 
Effect of Azone Pretreatment (Soaking Versus Surface 
Application) on Percutaneous Penetration of 
Benzocaine from 20/80 PG/Water Gel 
39 
Skin 
Condition 
Flux 
(Mcg/Cm2jHr) 
Relative 
Rate 
Correlation 
Coefficient 
( r) 
Intercept 
(Hrs) 
Soaking 76.55 (±2.69) 1.19 0.999 -0.42 
Surface 
Application 77.58 (±2.19) 1. 25 0.999 -1.00 
Control 1 64.57 (±2.08) 1 0.999 -1.07 
Control 2 61.88 (±3.82) 0.96 0.999 -1.35 
Benzocaine concentration in all preparations was 20 mg/ml. 
Control1 
Azone. 
No pretreatment. 20/80 PG/Water gel without 
Control 2 -No pretreatment. 20/80 PG/Water gel with 5% 
Azone. 
The fluxes from pretreated skin were significantly higher 
than controls (P < 0.01). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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tissues do not appear to be involved. The barrier-lowering 
effect on the skin appears to be the primary component of 
the overall mechanism of penetration enhancement by Azone. 
Effect of DMSO on the In-Vitro 
Percutaneous Penetration of 
Benzocaine 
This study was designed to complement the work done 
earlier in our laboratory on the effects of DMSO on percu-
taneous absorption of benzocaine. The previous study (29) 
suggested that DMSO/water systems did not enhance the pene-
tration of benzocaine into the stratum corneum when com-
pared to the control of 60/40 propylene glycol/water. This 
was attributed in part to the drug depletion effects, and 
the increased solubility of benzocaine in DMSO/water system 
and consequent decrease in partitioning of benzocaine into 
the receptor skin. 
The present study, conducted under the conditions of 
constant thermodynamic flux, suggested that DMSO signifi-
cantly enhanced the penetration of benzocaine into the skin 
as compared to control (Table IX, Fig. 9). The steady-
state fluxes were significantly increased with increasing 
DMSO concentration (P < 0.01). The DMSO-induced enhance-
ment of penetration was observed over 40-80% range of 
concentration of DMSO in the vehicle relative to 60/40 PG/ 
water control, also confirming that the lack of enhancement 
reported by Lam (29) was indeed due to drug depletion. 
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TABLE IX 
Penetration of Benzocaine from DMSO/Water Systems 
Through Full Thickness Human Skin 
DMSO/Water Correlation 
43 
System Flux Relative Coefficient Intercept 
(V/V) (Mcg/Cm2/Hr) Rate (r) (Hrs) 
80/20 49.52 (±5.25) 1. 62 0.990 0.95 
60/40 42.87 (±3.22) 1.40 0.995 0.78 
40/60 40.16 (±3.66) 1. 31 0.993 0.35 
Control 30.60 (±1. 57) 1 0.998 0.44 
Control = PG/water 60/40. 
Concentration of benzocaine in all systems was above satura-
tion throughout the duration of the experiment. 
The fluxes of all DMSO/Water curves were significantly 
different from control (P < 0.01). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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Earlier reports (18,19,33) have suggested that DMSO concen-
tration must be between 60 to 90% in order to see penetra-
tion enhancing effects. 
Exposure of skin to pure DMSO (surface pretreatment) 
for one hour resulted in a significant increase in the 
penetration rate of benzocaine over controls a and c (P < 
0.01) as shown in Table X, Figs. lOa and lOb. This sug-
gested that observed penetration enhancement might be due 
to a direct effect of the solvent on the stratum corneum. 
The pretreatment of the skin with DMSO resulted in an 
increase of approximately 50% in the total amount pene-
trated per unit area in the initial hour relative to 
control-1, declining to approximately 42% after six hours, 
then to only 20% after twelve hours. Apparently DMSO 
exerts a significant but temporary effect on the epidermal 
barrier. The effect lasts while the DMSO is held in the 
stratum corneum and then as it is absorbed or washed out, 
barrier function returns. 
The effect of duration of exposure to DMSO was not 
investigated during this study. 
Effect of 2-Pyrrolidone on the 
Percutaneous Penetration of 
Benzocaine 
The effect of 2-pyrrolidone on the percutaneous pene-
tration of benzocaine is summarized in Table XI, Fig. 11. 
The study was done using different mixtures of 2-pyrrolidone 
~-
TABLE X 
Percutaneous Penetration of Benzocaine Through 
DMSO-Pretreated Skin 
46 
System 
Identification 
Flux 
(Mcg/Cm2 /Hr) 
Correlation 
Coefficient 
(r) 
Intercept 
(Hrs) 
DMSO 
Pretreatment 34.94 (±1.00) 0.999 -1.33 
Control a 29.48 (±2.30) 0.994 -0.58 
Controlb 34.48 (±1.94) 0.997 -0.22 
Controlc 27.70 (±1.56) 0.997 -1.03 
aB . 
. enzocalne suspension in PG/Water 60/40. 
bB . enzocalne suspension in PG/Water 20/80. 
CB . enzocalne suspension in water. It was applied after 
pretreatment. 
The fluxes through pretreated skin were significantly 
different from those of controls a and c (P < 0.01). 
The numbers in parentheses indicate 95% confidence limits 
of the respective slope. 
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Figure lOa. Percutaneous Penetration of Benzocaine Through 
DMSO-Pretreated Skin. Q versus t plot. 
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TABLE XI 
Effect of 2-Pyrrolidone Concentration on Percutaneous 
Penetration of Benzocaine Through Full Thickness 
Human Skin 
Pyrrolidone/ Correlation 
Water System Flux Relative Coefficient Intercept 
(% V/V) (Mcg/Cm2/Hr) Rate ( r) (Hrs) 
10 38.75 (±1.63) 0.69 0.999 -0.84 
20 41.14 (±2.22) 0.73 0.998 -0.62 
40 52.35 (±2.81) 0.93 0.998 -0.57 
80 66.12 (±6.01) 1.18 0.994 -1.47 
Con trol-l 56.05 (±0.68) 1 0.999 -0.62 
Pre-
a 51.67 (±3.04) 0.92 0.997 0.59 treatment 
Control-1 = 20 mg/ml drug in PG/Water 20/80 suspension. 
Fluxes increased significantly as pyrrolidone concentrations 
increased (P < 0.01). 
Pretreatment showed no significant enhancement of penetra-
tion over control. 
The numbers in parentheses indicate 95% confidence limits of 
the respective slope. 
aThe skin was surface-pretreated with neat 2-P for one hour. 
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in water (10, 20, 40 and 80% V/V) to study its concen~ 
tration effect on benzocaine penetration and to also see if 
the observed enhancement, if any, was due to direct effect 
on the stratum corneum. The constant thermodynamic activity 
in the donor vehicle was ensured by adding drug in excess 
of the solubility in each vehicle. 
As can be seen from the results, the steady-state 
fluxes increased significantly (P < 0.01) with increasing 
pyrrolidone concentration. However, 2-pyrrolidone showed 
measurable enhancement over the control only at 80% V/V 
concentration. Furthermore, pretreatment of the skin with 
2-pyrrolidone by surface application for an hour produced 
no significant enhancement of benzocaine penetration over 
the control. Berry (24) has shown that 2-pyrrolidone 
behaves similarly to the aprotic solvent DMSO in the 
presence of small polar penetrants such as methanoli how-
ever, its effect on larger, more complex semi-polar or 
nonpolar molecules may not be easy to delineate. In the 
same study, the permeability coefficient, stratum corneum/ 
vehicle partition coefficient and diffusion coefficient of 
both caffeine and octanol were shown to decrease in the 
presence of 2-pyrrolidone. The moderate enhancement of 
benzocaine penetration observed in this study in the 
presence of 80% 2-pyrrolidone in water could be due to 
decrease in diffusional resistance of the stratum corneum 
brought on by a slow interaction with stratum corneum. 
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Additional studies including 2-pyrrolidone pretreatment, 
covering longer duration of exposure to the solvent, are 
needed in order to fully understand 2-pyrrolidone effect 
on percutaneous penetration of benzocaine and to draw 
meaningful conclusions. 
SUMMARY AND CONCLUSION 
The reported lack of efficacy of many OTC products 
containing benzocaine during clinical use has encouraged 
continuing efforts towards improving the percutaneous 
penetration of benzocaine. The present study combined the 
thermodynamic approach with the incorporation of various 
adjuvants in an attempt to maximize the in vitro percutan-
eous penetration of benzocaine. The strategy involved 
formulating each vehicle so as to sustain the optimum 
thermodynamic potential of the drug across the donor vehicle 
and receptor skin over a long period while maintaining a 
relatively high rate of drug transfer. The role of the 
so-called "penetration enhancers" Azone and dimethyl-
sulfoxide was investigated in this context. 2-Pyrrolidone 
was also briefly examined in view of the recent encouraging 
reports (24,25). 
Azone demonstrated a concentration-dependent enhance-
ment of benzocaine penetration through skin from Azone/ 
propylene glycol/water systems containing 1, 5 and 10% 
Azone respectively. At low drug levels (below saturation 
solubility), the incorporation of Azone in the formulation 
effectively compensated for the thermodynamic deficit. At 
high drug levels (drug in excess of solubility) 5% Azone 
appeared to have the maximum effect on the steady-state 
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fluxes from 20/80 PG/water system. Pretreatment studies 
demonstrated that penetration enhancement by Azone was 
significant, long lasting and largely due to a direct 
barrier-lowering effect on the stratum corneum. Benzocaine 
is extremely soluble in Azone. It would appear that the 
major penetration-enhancing effect of Azone is strongly 
negated by a reduction in vehicle to skin partitioning due 
to its high affinity for benzocaine. 
Under the conditions of the experiment, dimethyl-
sulfoxide enhanced the percutaneous penetration of benzo~ 
caine through full-thickness human skin at a concentration 
level of 40-80% in water. Pretreatment studies suggested 
that DMSO exerted a significant but temporary effect on the 
skin barrier. 
With 2-pyrrolidone, a significant enhancement over 
control was seen only at a very high 2-P level (80%). The 
results of the pretreatment studies were not conclusive. A 
direct barrier-lowering effect on the skin, if present, is 
relatively slow to take effect. Further investigation is 
warranted. 
In general, the three penetration enhancers examined 
have demonstrated significant penetration enhancement of 
benzocaine across human cadaver skin; however, the effects 
were not dramatic. Benzocaine readily penetrated the 
well-hydrated skin from the PG/water vehicle. The incor-
poration of Azone into this system might not be the most 
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effective way to take advantage of its considerable barrier-
lowering effect on stratum corneum, especially for hydro-
phobic drugs like benzocaine. With molecules of much lower 
intrinsic penetrability and high hydrophilicity, Azone 
might produce dramatic effects. The clinical potential for 
benzocaine formulations containing DMSO would appear to be 
limited due to its high concentration requirement and 
consequent possibilities for side effects. Although 2-P 
did not show promise with benzocaine it deserves further 
screening with a spectrum of drugs of different physical/ 
chemical characteristics in order to assess its full 
potential as adjuvant in dermatologic formulations. 
-
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APPENDIX A 
Beer's Law Plot of Benzocaine in 
Normal Saline 
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APPENDIX B 
Beer's Law Plot of Benzocaine 
in Ethanol 
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